Tandem Diabetes Care (TNDM) Gross Margin (2013 - 2026)
Tandem Diabetes Care posted quarterly Gross Margin of 55.33% for Q1 2026, up 482.0% year-on-year from 9.51% in Q1 2025, and down 4.05% on a QoQ basis from 57.67% in Q4 2025.
Tandem Diabetes Care (TNDM) has 14 years of Gross Margin data on file, last reported at 55.33% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 482.0% year-over-year to 55.33%; the trailing twelve-month figure through Mar 2026 stood at 54.93% (up 271.0% YoY), and the FY2025 full-year result was 53.81%, up 174.0% from the prior year.
- Gross Margin for Q1 2026 stood at 55.33%, down from 57.67% in the prior quarter.
- Across five years, Gross Margin topped out at 57.67% in Q4 2025 and bottomed at 47.41% in Q4 2023.
- The 5-year median for Gross Margin is 51.09% (2024), against an average of 51.73%.
- The widest annual swing landed in 2023, when Gross Margin sank 498 bps; it then surged 830 bps in 2024.
- A 5-year view of Gross Margin shows it stood at 52.39% in 2022, then dropped by 10 bps to 47.41% in 2023, then gained by 18 bps to 55.71% in 2024, then advanced by 4 bps to 57.67% in 2025, then decreased by 4 bps to 55.33% in 2026.
- The last three Gross Margin figures came in at 55.33% (Q1 2026), 57.67% (Q4 2025), and 53.88% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | 55.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.33% |
| Dec 31, 2025 | 57.67% |
| Sep 30, 2025 | 53.88% |
| Jun 30, 2025 | 52.29% |
| Mar 31, 2025 | 50.51% |
| Dec 31, 2024 | 55.71% |
| Sep 30, 2024 | 51.09% |
| Jun 30, 2024 | 50.83% |
| Mar 31, 2024 | 49.39% |
| Dec 31, 2023 | 47.41% |
| Sep 30, 2023 | 48.35% |
| Jun 30, 2023 | 51.93% |
| Mar 31, 2023 | 48.95% |
| Dec 31, 2022 | 52.39% |
| Sep 30, 2022 | 51.05% |
| Jun 30, 2022 | 50.91% |
| Mar 31, 2022 | 51.78% |
| Dec 31, 2021 | 54.16% |
| Sep 30, 2021 | 53.86% |
| Jun 30, 2021 | 53.71% |
| Mar 31, 2021 | 51.96% |
| Dec 31, 2020 | 53.88% |
| Sep 30, 2020 | 52.84% |
| Jun 30, 2020 | 49.79% |
| Mar 31, 2020 | 51.33% |
| Dec 31, 2019 | 55.60% |
| Sep 30, 2019 | 53.54% |
| Jun 30, 2019 | 53.51% |
| Mar 31, 2019 | 50.54% |
| Dec 31, 2018 | 54.51% |
| Sep 30, 2018 | 47.11% |
| Jun 30, 2018 | 44.21% |
| Mar 31, 2018 | 41.81% |
| Dec 31, 2017 | 43.35% |
| Sep 30, 2017 | 43.97% |
| Jun 30, 2017 | 37.52% |
| Mar 31, 2017 | 35.59% |
| Dec 31, 2016 | 34.81% |
| Sep 30, 2016 | -12.83% |
| Jun 30, 2016 | 35.57% |
| Mar 31, 2016 | 34.53% |
| Dec 31, 2015 | 46.22% |
| Sep 30, 2015 | 35.08% |
| Jun 30, 2015 | 30.57% |
| Mar 31, 2015 | 22.81% |
| Dec 31, 2014 | 36.54% |
| Sep 30, 2014 | 32.53% |
| Jun 30, 2014 | 33.63% |
| Mar 31, 2014 | 10.75% |
| Dec 31, 2013 | 11.60% |
| Sep 30, 2013 | 32.57% |
| Jun 30, 2013 | 7.34% |
| Mar 31, 2013 | 37.38% |